维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

17篇 您的检索式：作者名="Fiandra"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	AcMNPV ChiA protein disrupts the peritrophic membrane and alters midgut physiology of Bombyx mori larvae 显示文摘	Rao R Fiandra L Giordana B	2004	Insect Biochemistry and Molecular Biology2004，34，11：	1
	2	Prostate brachytherapy with iodine-125 seeds: radiation protection issues显示文摘	Anglesio S Calamia E Fiandra C	2005	Tumori2005，91，4：	1
	3	Prostate brachythera- py with iodine - 125 seeds: radiation protection issues 显示文摘	Anglesio S Calamia E Fiandra C	2005	Tumori2005，91，4：	1
	4	HER-2 expression in breast cancer cells is downregulated upon active targeting by antibody engineered multifunctional nanoparticles in mice显示文摘	Corsi F Fiandra L De Palma C	2011	ACS Nano2011，5，8：	1
	5	AcMNPV ChiA protein disrupts the peritrophic membrane and alters midgut physiology of Bombyx mori larvae显示文摘	Rao R Fiandra L Giordana B	2004	Insect Biochem Mol Biol2004，34，11：	1
	6	Prostate brachytherapy with iodine-125 seeds: radiation protection issues显示文摘	Anglesio S Calamia E Fiandra C	2005	Tumori2005，91，4：	1
	7	Intestinal permeability in Crohn’s disease patients and their first degree relatives显示文摘	M. Secondulfo L. de Magistris R. Fiandra L. Caserta M. Belletta M.T. Tartaglione G. Riegler F. Biagi G.R. Corazza R. Carratù	2001	Digestive and Liver Disease2001，，8：	1
	8	Dosimetric predictors of radiation-induced lung injury in stereotactic body radiation therapy显示文摘	Umberto Ricardi Andrea Riccardo Filippi Alessia Guarneri Francesca Romana Giglioli Cristina Mantovani Christian Fiandra Silvia Anglesio Riccardo Ragona	2009	Acta Oncologica2009，，4：	1
	9	Intestinal permeability in Crohn' s disease patients and their first degree relatives显示文摘	Secondulfo M de Magistris L Fiandra R	2001	Dig Liver Dis2001，33，8：	1
	10	AcMNPV ChiA protein disrupts the peritrophic membrane and alters midgut physiology of Bombyx mori larvae 显示文摘	Rao R Fiandra L Giordana B Eguileor M D Congiu T Burlini N Arciello S Corrado G and Pennacchio F	2004	Insect Biochemistry and Molecular Biology2004，34，：	1
	11	Index of myocardial performance after early phase of myocardial infarction in relation to its location 显示文摘	Cacciapuoti F Arciello A Fiandra M	2004	J Am Soc Echocardiogr2004，17，4：	1
	12	AcMNPV ChiA protein disrupts the peritrophic membrane and alters midgut physiology of Bombyx mori larvae显示文摘	Rao R Fiandra L Giordana B	2004	Insect Biochem Mol Biol2004，34，11：	1
	13	AcMNPV ChiA protein disrupts the peritrophic membrane and alters midgut physiolo- gy of Bombyz mori larvae 显示文摘	Rao R Fiandra L Giordana B	2004	Insect Biochemistry and Mo- lecular Biology2004，34，11：	1
	14	AcMNPV ChiA protein disrupts the peritrophic membrane and alters mid- gut physiology of Bombyx mori larvae 显示文摘	Rao R Fiandra L Giordana B	2004	Insect Bio-chemistry and Molecular Biology2004，，11：	1
	15	Prostate brachytherapy with iodine-125 seeds: radiation protection issues 显示文摘	Anglesio S Calamia E Fiandra C	2005	Tumori2005，91，4：	1
	16	Targeted approaches for HER2 breast cancer therapy: News from nanomedicine?显示文摘About 30% of human breast cancers are human epidermal growth factor receptor 2(HER2)+. This particular biological portrait is characterized by the overexpression of HER2 receptor with the subsequent deregulation of downstream pathways, which control cellular survival and proliferation. The most effective treatment for HER2+cancer is represented by therapy with HER2-targeted agents. Anti-HER2 therapy dramatically improves clinical outcomes, although it shows some limitations in achieving a proper treatment. These drawbacks of HER2-targeted therapy may be overcome with the development of HER2-targeted drug delivery nanodevices. These nanoparticles possess an internal three-dimensional compartimentalization, which allows to combine the specific target recognition with their capability to act as a drug reservoir for the selective delivery of chemotherapics to tumor sites. Moreover, nanoparticles useful in photothermal ablation or in photodynamic therapy have been functionalized in order to match specificity in tumor cell recognition and suitable chemical properties. Here, we summarize the state of the art concerning the HER2+breast cancer and anti-HER2 therapy, in particular deepening the contribution of the nanomedicine. Description of preclinical studies performed with HER2-targeted na-noparticles for HER2+ breast cancer therapy will be preceded by an overview on HER2-targeting molecules and nano-conjugation strategies. Further investigation will be necessary to introduce these nano-drugs in clinical practice; however promising results encourage an upcoming translation of this research for the next future.	Serena Mazzucchelli Marta Truffi Luisa Fiandra Luca Sorrentino Fabio Corsi	2014	World Journal of Pharmacology2014，3，4：	0
	17	Antiretroviral Therapy through Barriers: A Prominent Role for Nanotechnology in HIV-1 Eradication from Sanctuaries显示文摘	Fabio Corsi Luca Sorrentino Serena Mazzucchelli Marta Truffi Amedeo Capetti Giuliano Rizzardini Luisa Fiandra	2016	Journal of Pharmacy and Pharmacology2016，4，7：	0

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费